The global Antifungal Treatment market is expected to reach USD 13.39 Billion in 2028 and register a revenue CAGR of 1.4% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth include increasing prevalence of skin and fungal infections among all age groups, high demand for Antifungal Treatment in developing countries, and high geriatric population prone to fungal infections.

Over the recent years, there has been rapid increase in the prevalence of fungal infections across the globe owing to factors such as low immunity, constantly changing climatic conditions, and unhygienic lifestyles. Most fungal infections are non-lethal but can cause inconvenience to people suffering from them. Various Antifungal Treatment are used to prevent and treat different fungal infections such as athlete’s foot, candidiasis, ringworm, and jock itch. These drugs are either prescribed or are available over-the-counter in hospitals or retail pharmacies.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1399

One of the key factors fueling global market revenue growth is the rising prevalence of mucormycosis in patients suffering from coronavirus. Other factors such as improving healthcare infrastructure, rising disposable income, growing healthcare spending, favorable government schemes, and increasing investments in R&D activities are expected to fuel market growth.

However, factors such as increasing number of drug/product recalls, growing resistance against many Antifungal Treatment, and adverse effects of certain Antifungal Treatment such as itching, redness, nausea, diarrhea, or nephrotoxicity are expected to hamper overall market growth to a certain extent over the forecast period.

  Some key highlights of the report:

  • Based on route of administration, the oral segment is expected to register steady revenue CAGR between 2021 and 2028. This can be attributed to increasing prevalence of fungal infections and diseases, availability of many broad-spectrum antifungal oral drugs, high preference for tablets due to easy administration and quick absorption, and increasing production of new formulation drugs.
  • Based on distribution channel, the hospital pharmacies segment is expected to account for significant revenue share over the forecast period. This can be attributed to factors such as increasing patient visits to hospitals, availability of advanced antifungal creams and lotions in hospital pharmacies, improving healthcare infrastructure, and growing demand for prescription as well as over-the-counter drugs.
  • The European market is expected to account for steady revenue growth during the forecast period owing to factors such as high prevalence of skin infections and fungal diseases, increasing healthcare spending, presence of well-developed healthcare facilities, and availability of advanced treatments for fungal infections. Other factors such as increasing investments in research and development activities, high focus on developing more effective drugs for fungal diseases and infections, and presence of leading key players are expected to fuel market growth during the forecast period.
  • The market in Asia Pacific is expected to register a revenue CAGR of 1.9% over the forecast period owing to increasing prevalence of fungal infections, rising awareness about fungal diseases, growing R&D investments, rising healthcare spending, and improving healthcare infrastructure. Other factors such as favorable government initiatives, rising per capita income, and increasing demand for advanced skincare treatments are also expected to play an important role in growth of the Asia Pacific market.

  Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Antifungal Treatment market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:

Abbott Laboratories, Pfizer, Inc., Novartis AG, Merck & Co., Inc., Sanofi-Aventis, Bayer AG, Enzon Pharmaceuticals, Inc., GlaxoSmithKline Plc, Astellas Pharma, Inc., Gilead Sciences, Inc., Leadiant Biosciences, Inc., Sigma-Aldrich, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Mylan N.V, Maan Medex Private Ltd., Lifevision Healthcare, and Medico Remedies Limited

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1399

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

  Antifungal Treatment Market Segmentation:

Drug Class Outlook:

  • Azoles
    • Voriconazole
    • Posaconazole
    • Clotrimazole
    • Isavuconazole
    • Others
  • Echinocandins
    • Caspofungin
    • Micafungin
    • Others
  • Polyenes
    • Amphotericin B
    • Candicidin
    • Hamycin
    • Natamycin
    • Others
  • Allylamines
    • Terbinafine
    • Others
  • Others

Indication Outlook:

  • Candidiasis
    • Invasive Candidiasis
    • Vulvovaginal Candidiasis (VVC)
    • Mouth/Throat/Esophageal Candidiasis
    • Others
  • Dermatophytosis
  • Aspergillosis
  • Others

Distribution Channel Outlook:

  • Hospitals Pharmacies
  • Specialty Clinics
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

Some essential purposes of the Antifungal Treatment market research report:

  • Vital Developments: Custom investigation provides critical improvements to the Antifungal Treatment market, including R&D, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
  • Market Characteristics: The report contains Antifungal Treatment market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
  • Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Antifungal Treatment market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Antifungal Treatment market.
  • Convincingly, the Antifungal Treatment report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Antifungal Treatment market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1399

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

 

Urinary Incontinence Market @ https://www.biospace.com/article/urinary-incontinence-market-size-to-reach-usd-4-53-billion-in-2028-says-reports-and-data/

Tuberculosis Diagnostics Market @ https://www.biospace.com/article/tuberculosis-diagnostics-market-to-reach-usd-3-58-billion-by-2027-says-reports-and-data/

Medical Alert Systems Market @ https://www.biospace.com/article/increasing-adoption-of-tracking-devices-in-hospitals-and-introduction-of-hands-free-medical-alert-systems-to-drive-revenue-growth-of-the-market-reports-and-data-/

NGS Sample Preparation Market @ https://www.biospace.com/article/ngs-sample-preparation-market-to-reach-usd-5-42-billion-by-2028-says-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs